EP2217229 - PHARMACEUTICAL COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.08.2021 Database last updated on 02.11.2024 | |
Former | The patent has been granted Status updated on 11.09.2020 | ||
Former | Grant of patent is intended Status updated on 27.04.2020 | ||
Former | Examination is in progress Status updated on 04.01.2017 | Most recent event Tooltip | 17.06.2022 | Lapse of the patent in a contracting state New state(s): CY, HU, MT | published on 20.07.2022 [2022/29] | Applicant(s) | For all designated states Athenex, Inc. Conventus Building 1001 Main Street, Suite 600 Buffalo, NY 14203 / US | [2018/20] |
Former [2016/02] | For all designated states Athenex, Inc. 701 Ellicott Street Buffalo, NY 14203 / US | ||
Former [2012/21] | For all designated states Kinex Pharmaceuticals, LLC 701 Ellicott Street NY Center for Excellence in Bioinformatics and Life Sciences Buffalo, NY 14203 / US | ||
Former [2010/33] | For all designated states Kinex Pharmaceuticals, LLC NY Center for Excellence in Bioinformatics & Life Sciences 701 Ellicott Street Buffalo, NY 14203 / US | Inventor(s) | 01 /
HANGAUER, David, G. 166 Nichter Road Lancaster, NY 10486 / US | [2010/33] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [N/P] |
Former [2020/42] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | ||
Former [2013/15] | Mintz Levin Cohn Ferris Glovsky and Popeo LLP Alder Castle 10 Noble Street London EC2V 7JX / GB | ||
Former [2010/33] | Haile, Alison Victoria, et al Mintz Levin, Cohn, Ferris, Glovsky and Popeo IP, LLP Alder Castle 10 Noble Street London EC2V 7JX / GB | Application number, filing date | 08839636.1 | 20.10.2008 | [2010/33] | WO2008US11977 | Priority number, date | US20070999943P | 20.10.2007 Original published format: US 999943 P | [2010/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009051848 | Date: | 23.04.2009 | Language: | EN | [2009/17] | Type: | A1 Application with search report | No.: | EP2217229 | Date: | 18.08.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.04.2009 takes the place of the publication of the European patent application. | [2010/33] | Type: | B1 Patent specification | No.: | EP2217229 | Date: | 14.10.2020 | Language: | EN | [2020/42] | Search report(s) | International search report - published on: | EP | 23.04.2009 | Classification | IPC: | A61P35/02, A61P31/00, A61K31/7068 | [2020/10] | CPC: |
A61K31/216 (EP,US);
A61K31/5377 (EP,CN,US);
A61K31/138 (CN);
A61K31/435 (EP,US);
A61K31/44 (EP,US);
A61K31/535 (EP,US);
A61K31/555 (CN);
A61K31/7068 (CN);
A61K9/0019 (EP);
A61K9/0048 (EP);
A61P1/16 (EP);
A61P17/06 (EP);
A61P19/10 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P27/00 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P31/20 (EP);
A61P33/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P7/10 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D213/56 (EP,US)
(-)
| C-Set: |
A61K31/138, A61K2300/00 (CN);
A61K31/5377, A61K2300/00 (CN);
A61K31/555, A61K2300/00 (CN);
A61K31/7068, A61K2300/00 (CN) |
Former IPC [2010/33] | A61K31/216, A61K31/435, A61K31/44, A61K31/535, A61K31/5377, C07D213/55 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2020/42] |
Former [2010/33] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | PHARMAZEUTISCHE ZUBEREITUNG ZUR VERÄNDERUNG DER KINASE KASAKADE UND DEREN VERWENDUNG | [2020/10] | English: | PHARMACEUTICAL COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF | [2010/33] | French: | COMPOSITIONS PHARMACEUTIQUES POUR LA MODULATION D'UNE CASCADE DE KINASES ET LEURS PROCÉDÉS D'UTILISATION | [2010/33] |
Former [2010/33] | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR MODULIERUNG EINER KINASE-KASKADE UND ANWENDUNGSVERFAHREN DAFÜR | Entry into regional phase | 20.05.2010 | National basic fee paid | 20.05.2010 | Designation fee(s) paid | 20.05.2010 | Examination fee paid | Examination procedure | 20.05.2010 | Amendment by applicant (claims and/or description) | 20.05.2010 | Examination requested [2010/33] | 07.05.2014 | Despatch of a communication from the examining division (Time limit: M06) | 17.11.2014 | Reply to a communication from the examining division | 23.10.2015 | Despatch of a communication from the examining division (Time limit: M06) | 29.04.2016 | Reply to a communication from the examining division | 02.01.2017 | Despatch of a communication from the examining division (Time limit: M06) | 10.07.2017 | Reply to a communication from the examining division | 26.04.2018 | Despatch of a communication from the examining division (Time limit: M04) | 01.08.2018 | Reply to a communication from the examining division | 23.01.2020 | Cancellation of oral proceeding that was planned for 04.02.2020 | 04.02.2020 | Date of oral proceedings (cancelled) | 28.04.2020 | Communication of intention to grant the patent | 02.09.2020 | Fee for grant paid | 02.09.2020 | Fee for publishing/printing paid | 02.09.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20196756.9 / EP3777832 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.05.2014 | Opposition(s) | 15.07.2021 | No opposition filed within time limit [2021/38] | Fees paid | Renewal fee | 25.10.2010 | Renewal fee patent year 03 | 25.10.2011 | Renewal fee patent year 04 | 25.10.2012 | Renewal fee patent year 05 | 28.10.2013 | Renewal fee patent year 06 | 14.10.2014 | Renewal fee patent year 07 | 27.10.2015 | Renewal fee patent year 08 | 27.10.2016 | Renewal fee patent year 09 | 27.10.2017 | Renewal fee patent year 10 | 29.10.2018 | Renewal fee patent year 11 | 28.10.2019 | Renewal fee patent year 12 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 20.10.2008 | AT | 14.10.2020 | CY | 14.10.2020 | CZ | 14.10.2020 | DK | 14.10.2020 | EE | 14.10.2020 | FI | 14.10.2020 | HR | 14.10.2020 | LT | 14.10.2020 | LV | 14.10.2020 | MC | 14.10.2020 | MT | 14.10.2020 | NL | 14.10.2020 | PL | 14.10.2020 | RO | 14.10.2020 | SE | 14.10.2020 | SI | 14.10.2020 | SK | 14.10.2020 | TR | 14.10.2020 | IE | 20.10.2020 | LU | 20.10.2020 | BE | 31.10.2020 | CH | 31.10.2020 | LI | 31.10.2020 | BG | 14.01.2021 | NO | 14.01.2021 | GR | 15.01.2021 | IS | 14.02.2021 | PT | 15.02.2021 | [2022/27] |
Former [2022/26] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
DK | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SI | 14.10.2020 | ||
SK | 14.10.2020 | ||
TR | 14.10.2020 | ||
IE | 20.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2022/23] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
DK | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SI | 14.10.2020 | ||
SK | 14.10.2020 | ||
IE | 20.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2022/10] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
DK | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SI | 14.10.2020 | ||
SK | 14.10.2020 | ||
IE | 20.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
PT | 15.02.2021 | ||
Former [2021/50] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
DK | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SI | 14.10.2020 | ||
SK | 14.10.2020 | ||
IE | 20.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/46] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
DK | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SK | 14.10.2020 | ||
IE | 20.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/37] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
DK | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SK | 14.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/36] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
EE | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SK | 14.10.2020 | ||
LU | 20.10.2020 | ||
BE | 31.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/35] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
RO | 14.10.2020 | ||
SE | 14.10.2020 | ||
SK | 14.10.2020 | ||
LU | 20.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/34] | AT | 14.10.2020 | |
CZ | 14.10.2020 | ||
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
MC | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
SE | 14.10.2020 | ||
LU | 20.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/33] | AT | 14.10.2020 | |
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LT | 14.10.2020 | ||
LV | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
SE | 14.10.2020 | ||
LU | 20.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/31] | AT | 14.10.2020 | |
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LV | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
SE | 14.10.2020 | ||
LU | 20.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/28] | AT | 14.10.2020 | |
FI | 14.10.2020 | ||
HR | 14.10.2020 | ||
LV | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
SE | 14.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/25] | AT | 14.10.2020 | |
FI | 14.10.2020 | ||
LV | 14.10.2020 | ||
NL | 14.10.2020 | ||
PL | 14.10.2020 | ||
SE | 14.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
IS | 14.02.2021 | ||
PT | 15.02.2021 | ||
Former [2021/24] | AT | 14.10.2020 | |
FI | 14.10.2020 | ||
LV | 14.10.2020 | ||
NL | 14.10.2020 | ||
SE | 14.10.2020 | ||
BG | 14.01.2021 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
PT | 15.02.2021 | ||
Former [2021/23] | FI | 14.10.2020 | |
LV | 14.10.2020 | ||
NL | 14.10.2020 | ||
SE | 14.10.2020 | ||
NO | 14.01.2021 | ||
GR | 15.01.2021 | ||
PT | 15.02.2021 | ||
Former [2021/22] | FI | 14.10.2020 | |
NL | 14.10.2020 | ||
NO | 14.01.2021 | ||
PT | 15.02.2021 | ||
Former [2021/21] | FI | 14.10.2020 | |
NL | 14.10.2020 | ||
PT | 15.02.2021 | ||
Former [2021/20] | FI | 14.10.2020 | Cited in | International search | [A]WO03093248 (SMITHKLINE BEECHAM CORP [US], et al) [A] 1,21,30 * page 15 - page 16 *; | [X]US2006160800 (HANGAUER DAVID G JR [US]) [X] 1-30 * paragraphs [0002] - [0005] - [0229] , [0254] - [0265] *; | [PA]WO2007136790 (MANNKIND CORP [US], et al) [PA] 1-10* paragraph [0114]; claim 1 *; | [PX]WO2008002676 (KINEX PHARMACEUTICALS LLC [US], et al) [PX] 1-30 * paragraphs [0133] - [0156] - [0448] , [0711] *; | [PX]WO2008082637 (KINEX PHARMACEUTICALS LLC [US], et al) [PX] 1-30 * claims 1,7,11,13-23 * | by applicant | US7300931 | US20070999943 |